The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer
Abstract
BACKGROUND: Fecal occult blood testing, flexible sigmoidoscopy, and colonoscopy are used to screen patients for colorectal cancer. OBJECTIVE: To compare the cost-effectiveness of fecal occult blood testing, flexible sigmoidoscopy, and colonoscopy. DESIGN: The cost-effectiveness of the three screening strategies was compared by using computer models of a Markov process. In the model, a hypothetical population of 100 000 persons 50 years of age undergoes annual fecal occult blood testing, sigmoidoscopy every 5 years, or colonoscopy every 10 years. Positive results on fecal occult blood testing or adenomatous polyps found during sigmoidoscopy are worked up by using colonoscopy. After polypectomy, colonoscopy is repeated every 3 years until no polyps are found. DATA SOURCES: Transition rates were estimated from U.S. vital statistics and cancer statistics and from published data on the sensitivity, specificity, and efficacy of various screening techniques. Costs of screening and cancer care were estimated from Medicare reimbursement data. TARGET POPULATION: Persons 50 years of age in the general population. TIME HORIZON: The study population was followed annually until death. PERSPECTIVE: Third-party payer. OUTCOME MEASURE: Incremental cost-effectiveness ratio. RESULTS OF BASE-CASE ANALYSIS: Compared with colonoscopy, annual screening with fecal occult blood testing costs less but saves fewer life-years. A screening strategy based on flexible sigmoidoscopy every 5 or 10 years is less cost-effective than the other two screening methods. RESULTS OF SENSITIVITY ANALYSIS: Screening with fecal occult blood testing is more sensitive to changes in compliance rates, and it becomes easily dominated by colonoscopy under most conditions assuming less than perfect compliance. Other assumptions about the sensitivity and specificity of fecal occult blood testing, screening frequency, efficacy of colonoscopy in preventing cancer, and polyp incidence have a lesser influence on the differences in cost-effectiveness between colonoscopy and fecal occult blood testing. CONCLUSIONS: Colonoscopy represents a cost-effective means of screening for colorectal cancer because it reduces mortality at relatively low incremental costs. Low compliance rates render colonoscopy every 10 years the most cost-effective primary screening strategy for colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
Winawer, S. J., Zauber, A. G., Ho, M. N., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292701 · Cited by 4,592
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,229
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., James, P. D., & Mangham, C. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03386-7 · Cited by 2,793
Randomised study of screening for colorectal cancer with faecal-occult-blood test
Kronborg, O., Fenger, C., Olsen, J., Jørgensen, O. D., & Søndergaard, O. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03430-7 · Cited by 2,501
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
Foundations of Cost-Effectiveness Analysis for Health and Medical Practices
Weinstein, M. C., & Stason, W. B. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703312961304 · Cited by 2,119
A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer
Selby, J. V., Friedman, G. D., Quesenberry, C. P., & Weiss, N. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261001 · Cited by 1,702
Colorectal cancer screening: Clinical guidelines and rationale
Winawer, S., Fletcher, R., Miller, L., Godlee, F., Stolar, M., Mulrow, C., Woolf, S., Glick, S., Ganiats, T., Bond, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.agast970594 · Cited by 1,612
Screening for Colorectal Cancer
Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-5-373 · Cited by 1,200
Screening Sigmoidoscopy and Colorectal Cancer Mortality
Newcomb, P. A., Norfleet, R. G., Storer, B. E., Surawicz, T. S., & Marcus, P. M. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.20.1572 · Cited by 911
Cited by
WINAWER, S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50044 · Cited by 2,143
MORIKAWA, T., KATO, J., YAMAJI, Y., WADA, R., MITSUSHIMA, T., & SHIRATORI, Y. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.056 · Cited by 539
Pignone, M., Saha, S., Hoerger, T., & Mandelblatt, J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-2-200207160-00007 · Cited by 538
Risk of Perforation After Colonoscopy and Sigmoidoscopy: A Population-Based Study
Gatto, N. M., Frucht, H., Sundararajan, V., Jacobson, J. S., Grann, V. R., & Neugut, A. I. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.230 · Cited by 522
Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia
Schoenfeld, P., Cash, B., Flood, A., Dobhan, R., Eastone, J., Coyle, W., Kikendall, J. W., Kim, H. M., Weiss, D. G., Emory, T., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042990 · Cited by 489
Metadata
- Authors
- Sonnenberg, A., Delcò, F., & Inadomi, J. M.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2000-10-17
- Volume
- 133
- Issue
- 8
- Pages
- 573-584
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2102993164
- Cited by
- 612
- References
- 28
- FWCI
- 18.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer. https://app.cochat.ai/papers/10.7326/0003-4819-133-8-200010170-00007
- The paper
- Sonnenberg, A., Delcò, F., & Inadomi, J. M. (2000). Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-133-8-200010170-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.